Canada
· Delayed Price · Currency is CAD Kits Eyecare Statistics
Total Valuation
Kits Eyecare has a market cap or net worth of CAD 283.05 million. The enterprise value is 279.45 million.
| Market Cap | 283.05M |
| Enterprise Value | 279.45M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Kits Eyecare has 31.45 million shares outstanding. The number of shares has increased by 0.35% in one year.
| Shares Outstanding | 31.45M |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | +6.76% |
| Owned by Insiders (%) | 40.16% |
| Owned by Institutions (%) | 8.77% |
| Float | 8.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 263.16 |
| PS Ratio | 2.22 |
| PB Ratio | 5.40 |
| P/FCF Ratio | 72.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 140.22, with an EV/FCF ratio of 71.09.
| EV / Earnings | -247.09 |
| EV / Sales | 2.19 |
| EV / EBITDA | 140.22 |
| EV / EBIT | n/a |
| EV / FCF | 71.09 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 28.23.
| Current Ratio | 1.24 |
| Quick Ratio | 0.68 |
| Debt / Equity | 28.23 |
| Debt / EBITDA | 7.42 |
| Debt / FCF | 3.76 |
| Interest Coverage | -0.66 |
Financial Efficiency
Return on equity (ROE) is -2.15% and return on invested capital (ROIC) is -0.88%.
| Return on Equity (ROE) | -2.15% |
| Return on Assets (ROA) | -0.66% |
| Return on Capital (ROIC) | -0.88% |
| Revenue Per Employee | 892,483 |
| Profits Per Employee | -7,909 |
| Employee Count | 143 |
| Asset Turnover | 1.38 |
| Inventory Turnover | 5.63 |
Taxes
| Income Tax | -384,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.49% in the last 52 weeks. The beta is 0.27, so Kits Eyecare's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +69.49% |
| 50-Day Moving Average | 7.84 |
| 200-Day Moving Average | 6.36 |
| Relative Strength Index (RSI) | 61.90 |
| Average Volume (20 Days) | 29,799 |
Short Selling Information
The latest short interest is 14,456, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 14,456 |
| Short Previous Month | 16,245 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kits Eyecare had revenue of CAD 127.63 million and -1.13 million in losses. Loss per share was -0.04.
| Revenue | 127.63M |
| Gross Profit | 42.84M |
| Operating Income | -977,000 |
| Pretax Income | -1.52M |
| Net Income | -1.13M |
| EBITDA | 1.18M |
| EBIT | -977,000 |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 18.39 million in cash and 14.80 million in debt, giving a net cash position of 3.60 million or 0.11 per share.
| Cash & Cash Equivalents | 18.39M |
| Total Debt | 14.80M |
| Net Cash | 3.60M |
| Net Cash Per Share | 0.11 |
| Equity (Book Value) | 52.42M |
| Book Value Per Share | 1.67 |
| Working Capital | 7.13M |
Cash Flow
In the last 12 months, operating cash flow was 4.51 million and capital expenditures -583,000, giving a free cash flow of 3.93 million.
| Operating Cash Flow | 4.51M |
| Capital Expenditures | -583,000 |
| Free Cash Flow | 3.93M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 33.57%, with operating and profit margins of -0.77% and -0.89%.
| Gross Margin | 33.57% |
| Operating Margin | -0.77% |
| Pretax Margin | -1.19% |
| Profit Margin | -0.89% |
| EBITDA Margin | 0.92% |
| EBIT Margin | -0.77% |
| FCF Margin | 3.08% |
Dividends & Yields
Kits Eyecare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.35% |
| Shareholder Yield | -0.35% |
| Earnings Yield | -0.42% |
| FCF Yield | 1.39% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |